Clinical Trials Browser

Phase 2 × Carcinoma, Renal Cell × Gefitinib × Clear all

NCT00014183 2019-11-07

ZD 1839 in Treating Patients With Stage IV or Recurrent Kidney Cancer

Phase 2 Completed

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00467077 2017-03-17

Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer

Phase 2 Terminated

21 enrolled 8 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00012337 2013-06-24

ZD 1839 in Treating Patients With Metastatic Kidney Cancer

Phase 2 Completed

Carcinoma, Renal Cell, Kidney Neoplasms